Promising activity of the proteasome inhibitor bortezomib (VELCADE) in the treatment of indolent non-Hodgkin's lymphoma and mantle cell lymphoma: ASH poster session 517-II.

Owen O'Connor, John Wright, Craig Moskowitz, Jamie Muzzy, Barbara MacGregor-Cortelli, Paul Hamlin, David Straus, Elizabeth Trehu, David P. Schenkein, Andrew D. Zelenetz

Research output: Contribution to journalArticle

Abstract

Dr. O'Connor delivered the following material as a poster at the 2003 American Society of Hematology meeting highlighting results from his work with bortezomib in the treatment of non-Hodgkin's and mantle cell lymphoma. A full publication of his results will appear later this year. Abstract #2346 appears in Blood, Volume 102, issue 11, November 16, 2003. The American Society of Hematology Poster Session "Lymphoma: Treatment and Supportive Care" took place on Sunday, December 7, 2003.

Original languageEnglish (US)
JournalJournal of the National Comprehensive Cancer Network : JNCCN
Volume2 Suppl 4
StatePublished - Nov 1 2004
Externally publishedYes

Fingerprint

Mantle-Cell Lymphoma
Posters
Proteasome Inhibitors
Non-Hodgkin's Lymphoma
Blood Volume
Publications
Lymphoma
Bortezomib

ASJC Scopus subject areas

  • Oncology

Cite this

Promising activity of the proteasome inhibitor bortezomib (VELCADE) in the treatment of indolent non-Hodgkin's lymphoma and mantle cell lymphoma : ASH poster session 517-II. / O'Connor, Owen; Wright, John; Moskowitz, Craig; Muzzy, Jamie; MacGregor-Cortelli, Barbara; Hamlin, Paul; Straus, David; Trehu, Elizabeth; Schenkein, David P.; Zelenetz, Andrew D.

In: Journal of the National Comprehensive Cancer Network : JNCCN, Vol. 2 Suppl 4, 01.11.2004.

Research output: Contribution to journalArticle

O'Connor, Owen ; Wright, John ; Moskowitz, Craig ; Muzzy, Jamie ; MacGregor-Cortelli, Barbara ; Hamlin, Paul ; Straus, David ; Trehu, Elizabeth ; Schenkein, David P. ; Zelenetz, Andrew D. / Promising activity of the proteasome inhibitor bortezomib (VELCADE) in the treatment of indolent non-Hodgkin's lymphoma and mantle cell lymphoma : ASH poster session 517-II. In: Journal of the National Comprehensive Cancer Network : JNCCN. 2004 ; Vol. 2 Suppl 4.
@article{875809e9f3ac40f58554389041788088,
title = "Promising activity of the proteasome inhibitor bortezomib (VELCADE) in the treatment of indolent non-Hodgkin's lymphoma and mantle cell lymphoma: ASH poster session 517-II.",
abstract = "Dr. O'Connor delivered the following material as a poster at the 2003 American Society of Hematology meeting highlighting results from his work with bortezomib in the treatment of non-Hodgkin's and mantle cell lymphoma. A full publication of his results will appear later this year. Abstract #2346 appears in Blood, Volume 102, issue 11, November 16, 2003. The American Society of Hematology Poster Session {"}Lymphoma: Treatment and Supportive Care{"} took place on Sunday, December 7, 2003.",
author = "Owen O'Connor and John Wright and Craig Moskowitz and Jamie Muzzy and Barbara MacGregor-Cortelli and Paul Hamlin and David Straus and Elizabeth Trehu and Schenkein, {David P.} and Zelenetz, {Andrew D.}",
year = "2004",
month = "11",
day = "1",
language = "English (US)",
volume = "2 Suppl 4",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",

}

TY - JOUR

T1 - Promising activity of the proteasome inhibitor bortezomib (VELCADE) in the treatment of indolent non-Hodgkin's lymphoma and mantle cell lymphoma

T2 - ASH poster session 517-II.

AU - O'Connor, Owen

AU - Wright, John

AU - Moskowitz, Craig

AU - Muzzy, Jamie

AU - MacGregor-Cortelli, Barbara

AU - Hamlin, Paul

AU - Straus, David

AU - Trehu, Elizabeth

AU - Schenkein, David P.

AU - Zelenetz, Andrew D.

PY - 2004/11/1

Y1 - 2004/11/1

N2 - Dr. O'Connor delivered the following material as a poster at the 2003 American Society of Hematology meeting highlighting results from his work with bortezomib in the treatment of non-Hodgkin's and mantle cell lymphoma. A full publication of his results will appear later this year. Abstract #2346 appears in Blood, Volume 102, issue 11, November 16, 2003. The American Society of Hematology Poster Session "Lymphoma: Treatment and Supportive Care" took place on Sunday, December 7, 2003.

AB - Dr. O'Connor delivered the following material as a poster at the 2003 American Society of Hematology meeting highlighting results from his work with bortezomib in the treatment of non-Hodgkin's and mantle cell lymphoma. A full publication of his results will appear later this year. Abstract #2346 appears in Blood, Volume 102, issue 11, November 16, 2003. The American Society of Hematology Poster Session "Lymphoma: Treatment and Supportive Care" took place on Sunday, December 7, 2003.

UR - http://www.scopus.com/inward/record.url?scp=70349895631&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349895631&partnerID=8YFLogxK

M3 - Article

C2 - 19791425

AN - SCOPUS:70349895631

VL - 2 Suppl 4

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

ER -